Evidence map›Paper›PMID 41761863›Full record

ArticleJournal of internal medicine2026

The novel ITPR1 p.Phe2566Ser variant impairs IP

Josephine Wincent, Songbai Zhang, Andrew Nolan, Shigeaki Kanatani, Frida Nordin, Malin Kvarnung, Per Uhlén, Martin Paucar, Ilse Eidhof

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The novel ITPR1 p.Phe2566Ser variant impairs IPJournal of internal medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Josephine WincentDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Songbai ZhangDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Andrew NolanDivision of Eye and Vision, St. Erik Eye Hospital, Stockholm, Sweden.ORCID https://orcid.org/0009-0009-8689-2145
Shigeaki KanataniDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Frida NordinDepartment of Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden.
Malin KvarnungDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Per UhlénDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Martin PaucarDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-3735-1480
Ilse EidhofDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-1567-3078

Funding

and Cancer Research Foundations of Radiumhemmet 221353by an SSMF PG-22-0462Radiumhemmets ForskningsfonderRegion StockholmSvenska Sällskapet för Medicinsk ForskningSwedish Brain Foundationthe Swedish Brain Foundation FO2024-0057-TK-138the Swedish Cancer Society 22 2454 PjThe Swedish Cancer Societythe Swedish Research Council 2021-03108Vetenskapsrådet
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ataxiacalcium signalingitpr1miosis

Identifiers

PMID41761863
PMCPMC13061096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.